Alnylam Pharmaceuticals | ALNY

Aktienkurs
239.53
Täglich Wechseln
-5.98 -2.44%
Monatlich
-1.27%
Jährlich
-47.19%
Q3 Prognose
243.36

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-10-29 FY2026Q3 AM 1.97 2.90
2026-07-30 FY2026Q2 AM 1.84 1.61 0.32
2026-04-30 FY2026Q1 AM 1.99 0.99 -0.01
2026-02-12 FY2025Q4 AM 1.25 1.27 0.06
2025-10-30 FY2025Q3 AM 2.90 0.27 -0.50



Preis Chg Tag Jahr Datum
Takeda 5,968.00 22.00 0.37% 33.27% 2026-09-18
Acadia Pharmaceuticals 27.29 -0.16 -0.58% 11.75% 2026-09-18
Agios Pharmaceuticals 33.07 -0.54 -1.61% -12.28% 2026-09-18
Alnylam Pharmaceuticals 239.53 -5.98 -2.44% -47.19% 2026-09-18
Amgen 385.65 5.87 1.55% 35.12% 2026-09-18
Arrowhead Research 66.49 -1.25 -1.85% 116.65% 2026-09-18
Tectonic Therapeutic 27.00 -0.21 -0.77% 80.24% 2026-09-18
BioCryst Pharmaceuticals 8.68 -0.02 -0.23% 12.73% 2026-09-18
BioMarin Pharmaceutical 63.92 -1.16 -1.78% 17.59% 2026-09-18
Incyte 125.30 -2.32 -1.82% 44.81% 2026-09-18

Preis Tag Jahr Datum
USND 26523 104.25 0.39% 17.19% 2026-09-18